1-9 of 9
Badarch Uranchimeg
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Aminoflavone, a Ligand of the Aryl Hydrocarbon Receptor, Inhibits HIF-1α Expression in an AhR-Independent Fashion

Erika Terzuoli, Maura Puppo, Annamaria Rapisarda, Badarch Uranchimeg, Liang Cao, Angelika M. Burger, Marina Ziche, Giovanni Melillo
Journal: Cancer Research
Cancer Res (2010) 70 (17): 6837–6848.
https://doi.org/10.1158/0008-5472.CAN-10-1075
Published: 31 August 2010
View article titled, Aminoflavone, a Ligand of the Aryl Hydrocarbon Receptor, Inhibits HIF-1α Expression in an AhR-Independent Fashion
Open the PDF for Aminoflavone, a Ligand of the Aryl Hydrocarbon Receptor, Inhibits HIF-1α Expression in an AhR-Independent Fashion in another window
Includes: Supplementary data
Journal Articles

Abstract #256: Identification and characterization of a novel HIF-1 inhibitor that selectively induces DNA damage under hypoxic conditions.

Annamaria Rapisarda, Badarch Uranchimeg, Dominic Scudiero, Anna Ngo, Ng Siew Bee, Martin Everett, John Cardellina, Robert Shoemaker, Giovanni Melillo
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 256.
Published: 01 May 2009
View article titled, Abstract #256: Identification and characterization of a novel HIF-1 inhibitor that selectively induces DNA damage under hypoxic conditions.
Journal Articles

Abstract #266: Modulation of HIF-1\#945; mRNA processing by Aminoflavone: a novel mechanism of HIF-1\#945; inhibition in breast cancer cells.

Erika Terzuoli, Badarch Uranchimeg, Annamaria Rapisarda, Angelika Burger, Marina Ziche, Giovanni Melillo
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 266.
Published: 01 May 2009
View article titled, Abstract #266: Modulation of HIF-1\#945; mRNA processing by Aminoflavone: a novel mechanism of HIF-1\#945; inhibition in breast cancer cells.
Journal Articles

Abstract #250: Response of colon cancer cells to the hypoxic microenvironment: characterization of pathways involved in survival and tumorigenicity

Barbara Onnis, Badarch Uranchimeg, Annamaria Rapisarda, Robert Shoemaker, Giovanni Melillo
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 250.
Published: 01 May 2009
View article titled, Abstract #250: Response of colon cancer cells to the hypoxic microenvironment: characterization of pathways involved in survival and tumorigenicity
Journal Articles

A novel small-molecule HIF-1 inhibitor that increases HIF-1 alpha degradation

Mark Creighton-Gutteridge, Annamaria Rapisarda, Badarch Uranchimeg, John H. Cardellina, II, William A. Denny, Robert H. Shoemaker, Giovanni Melillo
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1448.
Published: 01 May 2005
View article titled, A novel small-molecule HIF-1 inhibitor that increases HIF-1 alpha degradation
Journal Articles

Schedule-dependent Inhibition of Hypoxia-inducible Factor-1α Protein Accumulation, Angiogenesis, and Tumor Growth by Topotecan in U251-HRE Glioblastoma Xenografts

Annamaria Rapisarda, Jessica Zalek, Melinda Hollingshead, Till Braunschweig, Badarch Uranchimeg, Carrie A. Bonomi, Suzanne D. Borgel, John P. Carter, Stephen M. Hewitt, Robert H. Shoemaker, Giovanni Melillo
Journal: Cancer Research
Cancer Res (2004) 64 (19): 6845–6848.
https://doi.org/10.1158/0008-5472.CAN-04-2116
Published: 01 October 2004
View article titled, Schedule-dependent Inhibition of Hypoxia-inducible Factor-1α Protein Accumulation, Angiogenesis, and Tumor Growth by Topotecan in U251-HRE Glioblastoma Xenografts
Open the PDF for Schedule-dependent Inhibition of Hypoxia-inducible Factor-1α Protein Accumulation, Angiogenesis, and Tumor Growth by Topotecan in U251-HRE Glioblastoma Xenografts in another window
Journal Articles

Inhibition of HIF-1 dependent luciferase and VEGF expression in U251 xenograft by topotecan

Annamaria Rapisarda, Badarch Uranchimeg, Melinda Hollingshead, Jessica Zalek, Carrie Bonomi, Suzanne Borgel, John Carter, Robert Shoemaker, Giovanni Melillo
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 130.
Published: 01 April 2004
View article titled, Inhibition of HIF-1 dependent luciferase and VEGF expression in U251 xenograft by topotecan
Journal Articles

Topoisomerase I-Mediated Inhibition of Hypoxia-Inducible Factor 1: Mechanism and Therapeutic Implications

Annamaria Rapisarda, Badarch Uranchimeg, Olivier Sordet, Yves Pommier, Robert H. Shoemaker, Giovanni Melillo
Journal: Cancer Research
Cancer Res (2004) 64 (4): 1475–1482.
https://doi.org/10.1158/0008-5472.CAN-03-3139
Published: 18 February 2004
View article titled, Topoisomerase I-Mediated Inhibition of Hypoxia-Inducible Factor 1: <subtitle>Mechanism and Therapeutic Implications</subtitle>
Open the PDF for Topoisomerase I-Mediated Inhibition of Hypoxia-Inducible Factor 1: <subtitle>Mechanism and Therapeutic Implications</subtitle> in another window
Journal Articles

Identification of Small Molecule Inhibitors of Hypoxia-inducible Factor 1 Transcriptional Activation Pathway

Annamaria Rapisarda, Badarch Uranchimeg, Dominic A. Scudiero, Mike Selby, Edward A. Sausville, Robert H. Shoemaker, Giovanni Melillo
Journal: Cancer Research
Cancer Res (2002) 62 (15): 4316–4324.
Published: 01 August 2002
View article titled, Identification of Small Molecule Inhibitors of Hypoxia-inducible Factor 1 Transcriptional Activation Pathway
Open the PDF for Identification of Small Molecule Inhibitors of Hypoxia-inducible Factor 1 Transcriptional Activation Pathway in another window